Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 1 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| NeuroBo Pharmaceuticals Inc | NRBO | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 3,68 | 10:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 3,68 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 1 | 1 | - | 2,8888 - 6,7499 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 11:14:15 | 1 | US$ 3,67 | USD |
Finanzwerte NRBO
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 17,85M | 4,85M | - | 0 | -12,47M | -2,57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News NeuroBo Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 30.4.2024 | 14:01 | PR Newswire (US) | NeuroBo to Present Latest Pre-Clinical Data on.. |
| 17.4.2024 | 14:05 | PR Newswire (US) | NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1.. |
| 01.4.2024 | 14:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of.. |
| 28.3.2024 | 13:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Reports Year End 2023 Financial.. |
| 13.3.2024 | 13:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Receives Safety Review Committee.. |
| 04.3.2024 | 14:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Appoints Seasoned Life Science.. |
| 04.3.2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.2.2024 | 14:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 29.2.2024 | 14:01 | PR Newswire (US) | NeuroBo Pharmaceuticals Receives First Site IRB Approval for.. |
| 14.2.2024 | 14:52 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12.2.2024 | 14:01 | PR Newswire (US) | NeuroBo Pharmaceuticals to Participate in the BIO CEO &.. |
| 01.2.2024 | 14:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum NeuroBo Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NRBO Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 3,05 | 3,68 | 3,00 | 3,42 | 26.728 | 0,63 | 20,66% |
| 1 Monat | 3,90 | 4,04 | 2,99 | 3,46 | 27.146 | -0,22 | -5,64% |
| 3 Monate | 4,50 | 6,7499 | 2,99 | 5,36 | 122.119 | -0,82 | -18,22% |
| 6 Monate | 3,28 | 6,7499 | 2,90 | 5,32 | 714.125 | 0,40 | 12,20% |
| 1 Jahr | 5,3832 | 6,7499 | 2,8888 | 5,00 | 487.193 | -1,70 | -31,64% |
| 3 Jahre | 854,40 | 1.576,80 | 2,8888 | 260,16 | 1.037.593 | -850,72 | -99,57% |
| 5 Jahre | 2.196,00 | 7.200,00 | 2,8888 | 321,69 | 750.712 | -2.192,32 | -99,83% |
